Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim

Quicklink Submitted By Sheila Samples No comments

Would you like to know how many people have read this article? Or how reputable the author is? Simply sign up for a Advocate premium membership and you'll automatically see this data on every article. Plus a lot more, too.

Managing Editor

Become a Fan
(49 fans)

Price Gouging Drug CEO Martin Shkreli
(Image by The Young Turks, Channel: TheYoungTurks) Details DMCA

Controversial pharmaceutical boss Martin Shkreli has has decided he’s not going to lower the price of his HIV medication after all. Shkreli’s company Turing Pharmaceuticals announced on Wednesday that it would provide volume discounts of its drug Daraprim to hospitals, but it appears that the company’s $750-a-pill price tag still stands. Turing and Shkreli attracted a firestorm of criticism in September after it was revealed the company had raised the price of Daraprim, a 62-year-old treatment for parasitic infections, to $750 a pill from $13.50 after acquiring it. The medicine once sold for $1 a pill.

Read the rest of the story HERE:

At www.theguardian.com

1 1
Rate It | View Ratings

Sheila Samples Social Media Pages:

Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.